Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer

por Müller, Volkmar, Clemens, Michael, Jassem, Jacek, Al-Sakaff, Nedal, Auclair, Petra, Nüesch, Eveline, Holloway, Debbie, Shing, Mona, Bang, Yung-Jue
Publicado 2018

Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform

por Ko, Andrew H, Kim, Kyu-Pyo, Siveke, Jens T, Lopez, Charles D, Lacy, Jill, O’Reilly, Eileen M, Macarulla, Teresa, Manji, Gulam A, Lee, Jeeyun, Ajani, Jaffer, Alsina Maqueda, Maria, Rha, Sun-Young, Lau, Janet, Al-Sakaff, Nedal, Allen, Simon, Lu, Danny, Shemesh, Colby S, Gan, Xinxin, Cha, Edward, Oh, Do-Youn
Publicado 2023